Aurobindo Pharma Share Plunges on Positive Phase-3 Results of Breast Cancer Drug
Aurobindo Pharma shares soared in the early trade after its subsidiary CuraTeQ Biologics broadcasted favourable results in the phase-3 clinical trial of Trastuzumab biosimilar. The...